The maintenance of a Buy rating and a $30 price target by a reputable analyst firm like HC Wainwright & Co. is likely to instill confidence among investors and could positively influence Annovis Bio's stock price in the short term. The reaffirmation of the price target suggests that the analyst sees continued upside potential in the stock, based on their analysis.